Market Research Report

Product code

915980

Europe Metabolomics Market Forecast 2019-2027

Published: November 8, 2019 |

Inkwood Research | 112 Pages | Delivery time: 2-3 business days

Price

Description
Table of Contents
List of Tables

Add to Compare

KEY FINDINGS

The metabolomics market in the European region is estimated to grow at a CAGR of 12.09% during the forecasted period. The presence of highly developed countries and the rising demand for quality medications are the most important factors propelling market growth.

MARKET INSIGHTS

The European region with regard to metabolomics is segregated into Spain, Italy, Germany, the United Kingdom, France, and the Rest of Europe. The collaborations between important market players and the local governing bodies with an aim to manufacture and introduce different types of diagnostic tests and medications are projected to be beneficial for the overall market. Metabolomics is in its introductory stages in the European region, yet is gaining traction among other market regions. In a region like Italy, there is a large presence of pharmaceutical companies, along with rising investments in the R&D activities. In terms of pharmaceutical production, Italy ranks second in the European region. The rise of the aforementioned factors is estimated to propel the usage of metabolomics. The well-established healthcare further strengthens the growth prospects of the region, along with the shifting preference for personalized medicine. Countries like Germany are projected to witness positive growth with regard to the metabolomics market. This is because of the rising pharmaceutical R&D, coupled with the prevalence of various diseases in the region.

COMPETITIVE INSIGHTS

The increasing strategies by the key companies in the market are augmenting market growth. Kore Technology Limited, Bruker Corporation, Leco Corporation, Danaher Corporation (Sciex), Human Metabolome Technologies, Inc., Biocrates Life Sciences Ag, Bio-Rad Laboratories, Inc., Creative Proteomics, etc. are among the key companies of the region.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation cater to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 28111

1. RESEARCH SCOPE

1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

2.1. SOURCES OF DATA

2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA

2.2. TOP-DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

3.1. MARKET SUMMARY
3.2. KEY FINDINGS

3.2.1. METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES ARE THE FASTEST GROWING PRODUCT & SERVICE
3.2.2. BIOMARKER DISCOVERY IS THE WIDELY USED APPLICATION
3.2.3. CANCER IS THE MOST PREVALENT INDICATION

4. MARKET DYNAMICS

4.1. MARKET SCOPE & DEFINITION
4.2. MARKET DRIVERS

4.2.1. GROWING INVESTMENTS IN THE METABOLOMICS DOMAIN BY THE PUBLIC AND PRIVATE SECTORS
4.2.2. RISE IN THE DEMAND FOR PERSONALIZED MEDICINES
4.2.3. UPSURGE IN THE INCIDENCES OF CHRONIC DISEASE

4.3. MARKET RESTRAINTS

4.3.1. LACK OF SKILLED PROFESSIONALS IN METABOLOMICS
4.3.2. HIGH COST OF THE INSTRUMENTS

4.4. MARKET OPPORTUNITIES

4.4.1. EMERGING APPLICATION OF METABOLOMICS IN HUMAN NUTRITION
4.4.2. GROWING USAGES IN THE EARLY DETECTION OF CHRONIC DISEASES

4.5. MARKET CHALLENGES

4.5.1. COMPLEX AND DIVERSE NATURE OF THE BIOLOGICAL SAMPLES

5. MARKET BY PRODUCT & SERVICE

5.1. METABOLOMICS INSTRUMENTS

5.1.1. SEPARATION TECHNIQUE
5.1.2. DETECTION TECHNIQUE

5.2. METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES

6. MARKET BY APPLICATION

6.1. BIOMARKER DISCOVERY
6.2. DRUG DISCOVERY
6.3. TOXICOLOGY TESTING
6.4. NUTRIGENOMICS
6.5. FUNCTIONAL GENOMICS
6.6. PERSONALIZED MEDICINE
6.7. OTHER APPLICATION

7. MARKET BY INDICATION

7.1. CANCER
7.2. CARDIOVASCULAR DISORDERS
7.3. NEUROLOGICAL DISORDERS
7.4. INBORN ERRORS OF METABOLISM
7.5. OTHER INDICATION

8. KEY ANALYTICS

8.1. PORTER'S FIVE FORCES MODEL

8.1.1. THREAT OF NEW ENTRANTS
8.1.2. THREAT OF SUBSTITUTE
8.1.3. BARGAINING POWER OF BUYERS
8.1.4. BARGAINING POWER OF SUPPLIERS
8.1.5. THREAT OF COMPETITIVE RIVALRY

8.2. VALUE CHAIN ANALYSIS
8.3. MARKET TRENDS
8.4. OPPORTUNITY MATRIX

9. GEOGRAPHICAL ANALYSIS

9.1. EUROPE

9.1.1. GERMANY
9.1.2. FRANCE
9.1.3. THE UNITED KINGDOM
9.1.4. ITALY
9.1.5. SPAIN
9.1.6. REST OF EUROPE

10. COMPETITIVE LANDSCAPE

10.1. MARKET POSITION ANALYSIS
10.2. COMPANY PROFILES

10.2.1. AGILENT TECHNOLOGIES, INC.
10.2.2. APICAL SCIENTIFIC SDN BHD
10.2.3. BIOCRATES LIFE SCIENCES AG
10.2.4. BIO-RAD LABORATORIES, INC.
10.2.5. BRUKER CORPORATION
10.2.6. CREATIVE PROTEOMICS
10.2.7. DANAHER CORPORATION (SCIEX)
10.2.8. HUMAN METABOLOME TECHNOLOGIES, INC.
10.2.9. KORE TECHNOLOGY LIMITED
10.2.10. LECO CORPORATION
10.2.11. METABOLON INC.
10.2.12. PERKINELMER, INC.
10.2.13. SHIMADZU CORPORATION
10.2.14. THERMO FISHER SCIENTIFIC INC.
10.2.15. WATERS CORPORATION

LIST OF TABLES

TABLE 1: EUROPE METABOLOMICS MARKET, 2019-2027 ($ MILLION)
TABLE 2: EUROPE METAGENOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)
TABLE 3: EUROPE METABOLOMICS INSTRUMENTS MARKET, 2019-2027 ($ MILLION)
TABLE 4: EUROPE METABOLOMICS INSTRUMENTS MARKET, BY TYPE, 2019-2027 ($ MILLION)
TABLE 5: EUROPE SEPARATION TECHNIQUE MARKET, 2019-2027 ($ MILLION)
TABLE 6: EUROPE DETECTION TECHNIQUE MARKET, 2019-2027 ($ MILLION)
TABLE 7: EUROPE METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES MARKET, 2019-2027 ($ MILLION)
TABLE 8: EUROPE METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
TABLE 9: EUROPE BIOMARKER DISCOVERY MARKET, 2019-2027 ($ MILLION)
TABLE 10: EUROPE DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
TABLE 11: EUROPE TOXICOLOGY TESTING MARKET, 2019-2027 ($ MILLION)
TABLE 12: EUROPE NUTRIGENOMICS MARKET, 2019-2027 ($ MILLION)
TABLE 13: EUROPE FUNCTIONAL GENOMICS MARKET, 2019-2027 ($ MILLION)
TABLE 14: EUROPE PERSONALIZED MEDICINE MARKET, 2019-2027 ($ MILLION)
TABLE 15: EUROPE OTHER APPLICATION MARKET, 2019-2027 ($ MILLION)
TABLE 16: EUROPE METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)
TABLE 17: EUROPE CANCER MARKET, 2019-2027 ($ MILLION)
TABLE 18: EUROPE CARDIOVASCULAR DISORDERS MARKET, 2019-2027 ($ MILLION)
TABLE 19: EUROPE NEUROLOGICAL DISORDERS MARKET, 2019-2027 ($ MILLION)
TABLE 20: EUROPE INBORN ERRORS OF METABOLISM MARKET, 2019-2027 ($ MILLION)
TABLE 21: EUROPE OTHER INDICATION MARKET, 2019-2027 ($ MILLION)
TABLE 22: EUROPE METABOLOMIC SMARKET, BY COUNTRY, 2019-2027 ($ MILLION)
TABLE 23: GERMANY METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)
TABLE 24: GERMANY METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
TABLE 25: GERMANY METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)
TABLE 26: FRANCE METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)
TABLE 27: FRANCE METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
TABLE 28: FRANCE METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)
TABLE 29: THE UNITED KINGDOM METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)
TABLE 30: THE UNITED KINGDOM METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
TABLE 31: THE UNITED KINGDOM METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)
TABLE 32: ITALY METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)
TABLE 33: ITALY METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
TABLE 34: ITALY METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)
TABLE 35: SPAIN METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)
TABLE 36: SPAIN METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
TABLE 37: SPAIN METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)
TABLE 38: METABOLOMICS COMPANY MARKET POSITION ANALYSIS, 2018

LIST OF FIGURES

FIGURE 1: EUROPE METABOLOMICS MARKET, 2019-2027 ($ MILLION)
FIGURE 2: EUROPE METAGENOMICS MARKET, BY METABOLOMICS INSTRUMENTS, 2019-2027 ($ MILLION)
FIGURE 3: EUROPE METABOLOMICS INSTRUMENTS MARKET, BY SEPARATION TECHNIQUE, 2019-2027 ($ MILLION)
FIGURE 4: EUROPE METABOLOMICS INSTRUMENTS MARKET, BY DETECTION TECHNIQUE, 2019-2027 ($ MILLION)
FIGURE 5: EUROPE METAGENOMICS MARKET, BY METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES, 2019-2027 ($ MILLION)
FIGURE 6: EUROPE METABOLOMICS MARKET, BY BIOMARKER DISCOVERY, 2019-2027 ($ MILLION)
FIGURE 7: EUROPE METABOLOMICS MARKET, BY DRUG DISCOVERY, 2019-2027 ($ MILLION)
FIGURE 8: EUROPE METABOLOMICS MARKET, BY TOXICOLOGY TESTING, 2019-2027 ($ MILLION)
FIGURE 9: EUROPE METABOLOMICS MARKET, BY NUTRIGENOMICS, 2019-2027 ($ MILLION)
FIGURE 10: EUROPE METABOLOMICS MARKET, BY FUNCTIONAL GENOMICS, 2019-2027 ($ MILLION)
FIGURE 11: EUROPE METABOLOMICS MARKET, BY PERSONALIZED MEDICINE, 2019-2027 ($ MILLION)
FIGURE 12: EUROPE METABOLOMICS MARKET, BY OTHER APPLICATION, 2019-2027 ($ MILLION)
FIGURE 13: EUROPE METABOLOMICS MARKET, BY CANCER, 2019-2027 ($ MILLION)
FIGURE 14: EUROPE METABOLOMICS MARKET, BY CARDIOVASCULAR DISORDERS, 2019-2027 ($ MILLION)
FIGURE 15: EUROPE METABOLOMICS MARKET, BY NEUROLOGICAL DISORDERS, 2019-2027 ($ MILLION)
FIGURE 16: EUROPE METABOLOMICS MARKET, BY INBORN ERRORS OF METABOLISM, 2019-2027 ($ MILLION)
FIGURE 17: EUROPE METABOLOMICS MARKET, BY OTHER INDICATION, 2019-2027 ($ MILLION)
FIGURE 18: PORTER'S FIVE FORCE MODEL
FIGURE 19: GERMANY METABOLOMICS MARKET, 2019-2027 ($ MILLION)
FIGURE 20: FRANCE METABOLOMICS MARKET, 2019-2027 ($ MILLION)
FIGURE 21: THE UNITED KINGDOM METABOLOMICS MARKET, 2019-2027 ($ MILLION)
FIGURE 22: ITALY METABOLOMICS MARKET, 2019-2027 ($ MILLION)
FIGURE 23: SPAIN METABOLOMICS MARKET, 2019-2027 ($ MILLION)
FIGURE 24: REST OF EUROPE METABOLOMICS MARKET, 2019-2027 ($ MILLION)